We represented QualDerm Partners, a company that creates market-leading dermatology practice partnerships through affiliations and de novo development, in its acquisition of SkinMD, PLLC, a Nashville-based dermatology practice. Terms of the transaction were not disclosed.
QualDerm Partners Acquires SkinMD
You Also May Be Interested In:
ALS Education’s Charter School Management Business Sold to Satori Capital, Epic Partners Backed Company
Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.